Lactose (India) Ltd | 155 Cr. | 110 | 247/84.3 | 22.4 | 36.5 | 0.00 % | 18.0 % | 15.5 % | 10.0 |
MPS Pharmaa Ltd | 5.77 Cr. | 3.02 | 4.33/2.75 | | 0.80 | 0.00 % | 9.15 % | 34.9 % | 10.0 |
Gujarat Themis Biosyn Ltd | 2,663 Cr. | 244 | 390/192 | 50.6 | 20.5 | 0.27 % | 45.0 % | 33.8 % | 1.00 |
Gujarat Terce Laboratories Ltd | 45.4 Cr. | 61.2 | 94.9/44.5 | 15.4 | 11.9 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 35.2 Cr. | 24.0 | 29.0/12.3 | 35.9 | 6.64 | 0.00 % | 2.65 % | 2.08 % | 10.0 |
Godavari Drugs Ltd | 73.0 Cr. | 96.9 | 155/79.0 | 11.8 | 55.4 | 0.00 % | 14.4 % | 15.5 % | 10.0 |
Glenmark Life Sciences Ltd | 13,316 Cr. | 1,084 | 1,335/666 | 31.4 | 207 | 2.07 % | 28.1 % | 21.1 % | 2.00 |
Gennex Laboratories Ltd | 300 Cr. | 13.2 | 29.0/11.4 | 16.1 | 7.93 | 0.00 % | 14.1 % | 10.2 % | 1.00 |
Ganga Pharmaceuticals Ltd | 5.41 Cr. | 11.2 | 27.1/9.25 | 108 | 14.6 | 0.00 % | 3.06 % | 0.80 % | 10.0 |
Fredun Pharmaceuticals Ltd | 317 Cr. | 671 | 1,024/635 | 16.9 | 277 | 0.10 % | 17.1 % | 14.3 % | 10.0 |
Fervent Synergies Ltd | 97.2 Cr. | 22.2 | 32.0/14.6 | | 8.11 | 0.00 % | 34.8 % | 34.9 % | 10.0 |
Fermenta Biotech Ltd | 809 Cr. | 275 | 449/145 | 23.0 | 98.6 | 0.45 % | 3.20 % | 5.59 % | 5.00 |
Fabino Enterprises Ltd | 5.21 Cr. | 24.8 | 36.5/22.8 | 104 | 20.0 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
Evoq Remedies Ltd | 7.25 Cr. | 2.91 | 12.3/2.11 | 80.6 | 17.9 | 0.00 % | 0.44 % | 0.36 % | 10.0 |
Everest Organics Ltd | 302 Cr. | 311 | 324/112 | | 50.6 | 0.00 % | 6.05 % | 0.30 % | 10.0 |
Entero Healthcare Solutions Ltd | 5,691 Cr. | 1,310 | 1,584/991 | 63.2 | 387 | 0.00 % | 6.71 % | 4.98 % | 10.0 |
Murae Organisor Ltd | 117 Cr. | 1.26 | 2.72/1.03 | 24.9 | 2.85 | 0.00 % | 0.79 % | 0.13 % | 2.00 |
Dipna Pharmachem Ltd | 40.1 Cr. | 16.7 | 18.1/6.40 | 48.3 | 15.8 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
Decipher Labs Ltd | 11.4 Cr. | 11.3 | 24.6/10.0 | 49.6 | 21.3 | 0.00 % | 3.09 % | 6.75 % | 10.0 |
Coral Laboratories Ltd | 238 Cr. | 667 | 999/355 | 8.76 | 570 | 0.30 % | 12.6 % | 9.58 % | 10.0 |
Concord Drugs Ltd | 31.3 Cr. | 31.3 | 45.0/26.1 | | 33.9 | 0.00 % | 4.48 % | 1.28 % | 10.0 |
Colinz Laboratories Ltd | 24.2 Cr. | 53.0 | 88.7/36.0 | 49.4 | 20.5 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
Cian Healthcare Ltd | 7.87 Cr. | 3.15 | 26.5/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 19.3 Cr. | 129 | 154/55.1 | 48.3 | 91.1 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
Checkpoint Trends Ltd | 11.3 Cr. | 20.7 | 20.7/6.08 | | 0.93 | 0.00 % | 3.36 % | 5.77 % | 10.0 |
Chandra Bhagat Pharma Ltd | 41.5 Cr. | 55.0 | 124/50.0 | 26.3 | 39.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
Brawn Biotech Ltd | 5.48 Cr. | 18.2 | 27.8/15.5 | | 14.1 | 0.00 % | 25.9 % | 21.8 % | 10.0 |
Blue Jet Healthcare Ltd | 12,954 Cr. | 747 | 969/347 | 55.2 | 53.3 | 0.13 % | 30.0 % | 22.4 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 100 Cr. | 23.2 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 11.0 Cr. | 21.7 | 46.0/20.3 | 138 | 18.3 | 0.00 % | 11.6 % | 8.95 % | 10.0 |
BDH Industries Ltd | 157 Cr. | 273 | 418/245 | 16.1 | 110 | 1.65 % | 20.6 % | 16.9 % | 10.0 |
Bacil Pharma Ltd | 24.4 Cr. | 41.5 | 62.6/14.8 | 69.8 | 2.87 | 0.00 % | 13.1 % | 13.8 % | 10.0 |
Aurobindo Pharma Ltd | 66,384 Cr. | 1,133 | 1,593/994 | 18.7 | 527 | 0.40 % | 14.1 % | 11.5 % | 1.00 |
Auro Laboratories Ltd | 153 Cr. | 245 | 307/156 | 43.9 | 69.6 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
Anuh Pharma Ltd | 872 Cr. | 174 | 261/148 | 17.4 | 60.5 | 1.44 % | 25.6 % | 19.5 % | 5.00 |
ANG Lifesciences India Ltd | 36.0 Cr. | 27.6 | 62.8/21.0 | | 56.2 | 0.00 % | 1.78 % | 8.72 % | 10.0 |
Ami Organics Ltd | 9,500 Cr. | 2,323 | 2,644/1,008 | 78.1 | 294 | 0.13 % | 16.0 % | 9.37 % | 10.0 |
Amerise Biosciences Ltd | 5.88 Cr. | 0.89 | 1.45/0.55 | | 0.80 | 0.00 % | 2.73 % | 2.75 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 298 Cr. | 38.9 | 77.7/34.1 | 21.0 | 18.3 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
Adline Chem Lab Ltd | 5.77 Cr. | 9.87 | 26.0/9.40 | | 2.70 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 77.3 Cr. | 3.28 | 6.25/2.82 | 117 | 1.32 | 0.00 % | 3.27 % | 2.52 % | 1.00 |
Abbott India Ltd | 65,155 Cr. | 30,710 | 31,900/25,200 | 48.8 | 1,657 | 1.34 % | 46.0 % | 34.9 % | 10.0 |
Aarti Pharmalabs Ltd | 6,511 Cr. | 717 | 837/470 | 26.1 | 205 | 0.42 % | 16.6 % | 13.1 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 156 Cr. | 55.2 | 75.8/31.3 | 27.3 | 47.8 | 0.00 % | 6.09 % | 3.74 % | 10.0 |
Zota Health Care Ltd | 2,395 Cr. | 862 | 1,078/440 | | 57.7 | 0.12 % | 7.32 % | 16.8 % | 10.0 |
Wockhardt Ltd | 22,634 Cr. | 1,392 | 1,680/489 | | 209 | 0.00 % | 0.83 % | 12.1 % | 5.00 |
Wanbury Ltd | 843 Cr. | 259 | 325/131 | 45.4 | 11.8 | 0.00 % | 60.6 % | % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 3.12 | 0.00 % | 9.38 % | 233 % | 2.00 |
Venus Remedies Ltd | 418 Cr. | 313 | 428/270 | 15.0 | 370 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
Unichem Laboratories Ltd | 4,385 Cr. | 623 | 950/501 | 51.8 | 341 | 0.00 % | 0.39 % | 1.17 % | 2.00 |
TTK Healthcare Ltd | 1,762 Cr. | 1,239 | 1,923/991 | 25.7 | 735 | 0.81 % | 8.67 % | 6.43 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,08,953 Cr. | 3,223 | 3,591/2,513 | 58.5 | 222 | 0.87 % | 23.2 % | 24.2 % | 5.00 |
Themis Medicare Ltd | 1,200 Cr. | 131 | 317/115 | 26.0 | 44.8 | 0.38 % | 13.5 % | 11.8 % | 1.00 |
Syncom Formulations (India) Ltd | 1,639 Cr. | 17.4 | 27.9/11.0 | 43.0 | 3.32 | 0.00 % | 10.2 % | 8.51 % | 1.00 |
Suven Pharmaceuticals Ltd | 30,451 Cr. | 1,196 | 1,360/597 | 109 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
Suven Life Sciences Ltd | 2,754 Cr. | 126 | 169/83.0 | | 8.84 | 0.00 % | 36.4 % | 36.3 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 4,06,196 Cr. | 1,693 | 1,960/1,377 | 34.4 | 288 | 0.80 % | 17.3 % | 16.7 % | 1.00 |
Solara Active Pharma Sciences Ltd | 1,871 Cr. | 519 | 886/367 | | 301 | 0.00 % | 8.67 % | 33.5 % | 10.0 |
SMS Pharmaceuticals Ltd | 1,804 Cr. | 213 | 398/175 | 28.3 | 70.6 | 0.19 % | 11.2 % | 9.27 % | 1.00 |
SMS Lifesciences India Ltd | 378 Cr. | 1,270 | 1,750/626 | 18.0 | 621 | 0.12 % | 6.89 % | 3.66 % | 10.0 |
Shilpa Medicare Ltd | 6,477 Cr. | 662 | 960/418 | 76.5 | 238 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
Sequent Scientific Ltd | 3,626 Cr. | 145 | 241/91.8 | 241 | 27.2 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
Sanofi India Ltd | 14,270 Cr. | 6,207 | 7,600/4,146 | 39.4 | 374 | 1.88 % | 49.2 % | 38.6 % | 10.0 |
RPG Life Sciences Ltd | 3,592 Cr. | 2,185 | 2,977/1,381 | 37.6 | 229 | 0.73 % | 34.6 % | 25.5 % | 8.00 |
Procter & Gamble Health Ltd | 8,647 Cr. | 5,200 | 5,850/4,637 | 35.2 | 368 | 1.54 % | 45.0 % | 33.5 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 233 Cr. | 66.0 | 87.5/31.9 | | 19.0 | 0.00 % | 27.6 % | 16.8 % | 10.0 |
Pfizer Ltd | 19,250 Cr. | 4,202 | 6,453/3,701 | 31.3 | 820 | 0.83 % | 22.0 % | 16.1 % | 10.0 |
Par Drugs & Chemicals Ltd | 122 Cr. | 99.0 | 348/81.0 | 7.89 | 78.6 | 0.00 % | 25.0 % | 18.5 % | 10.0 |
Panacea Biotec Ltd | 3,051 Cr. | 498 | 498/112 | | 136 | 0.00 % | 3.57 % | 3.17 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 3,937 Cr. | 776 | 1,998/670 | 35.7 | 241 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
Neuland Laboratories Ltd | 16,363 Cr. | 12,749 | 18,100/5,540 | 68.2 | 1,087 | 0.11 % | 33.3 % | 26.4 % | 10.0 |
Nectar Lifescience Ltd | 511 Cr. | 22.9 | 56.5/21.0 | 30.1 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
Natco Pharma Ltd | 14,792 Cr. | 827 | 1,639/660 | 7.94 | 399 | 1.15 % | 30.1 % | 25.9 % | 2.00 |
Morepen Laboratories Ltd | 2,864 Cr. | 52.3 | 101/41.7 | 22.7 | 20.3 | 0.00 % | 16.8 % | 12.0 % | 2.00 |
Marksans Pharma Ltd | 9,674 Cr. | 214 | 359/130 | 26.3 | 50.3 | 0.28 % | 20.6 % | 16.5 % | 1.00 |
Mangalam Drugs and Organics Ltd | 121 Cr. | 80.3 | 145/70.1 | 11.7 | 93.2 | 0.00 % | 1.19 % | 6.12 % | 10.0 |
Lyka Labs Ltd | 382 Cr. | 108 | 177/90.2 | 93.1 | 27.7 | 0.00 % | 3.53 % | 5.07 % | 10.0 |
Lupin Ltd | 88,342 Cr. | 1,934 | 2,403/1,493 | 30.8 | 343 | 0.41 % | 15.7 % | 14.1 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,157 Cr. | 575 | 980/498 | 12.9 | 319 | 0.31 % | 22.3 % | 16.8 % | 10.0 |
Laurus Labs Ltd | 33,792 Cr. | 627 | 646/385 | 135 | 79.2 | 0.13 % | 7.50 % | 5.43 % | 2.00 |
Kwality Pharmaceuticals Ltd | 845 Cr. | 815 | 1,070/442 | 24.0 | 234 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 168 Cr. | 78.7 | 129/60.3 | | 60.4 | 0.00 % | 19.0 % | % | 10.0 |
Kopran Ltd | 993 Cr. | 206 | 370/155 | 20.9 | 103 | 1.46 % | 13.8 % | 11.0 % | 10.0 |
Kilitch Drugs (India) Ltd | 543 Cr. | 340 | 405/271 | 30.3 | 118 | 0.00 % | 12.6 % | 7.71 % | 10.0 |
Jubilant Pharmova Ltd | 14,590 Cr. | 916 | 1,310/617 | 43.8 | 373 | 0.55 % | 6.74 % | 0.76 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 25,353 Cr. | 1,628 | 2,030/1,303 | 39.6 | 207 | 0.75 % | 24.6 % | 20.0 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,456 Cr. | 220 | 328/109 | 40.0 | 29.7 | 0.91 % | 17.0 % | 13.0 % | 2.00 |
Ipca Laboratories Ltd | 35,850 Cr. | 1,409 | 1,758/1,052 | 48.8 | 264 | 0.28 % | 12.8 % | 9.35 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 1,884 Cr. | 64.2 | 108/57.5 | 19.3 | 56.5 | 1.56 % | 12.3 % | 8.68 % | 2.00 |
Ind-Swift Ltd | 72.8 Cr. | 13.4 | 34.7/12.5 | 1.13 | 122 | 0.00 % | 13.4 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 523 Cr. | 86.2 | 186/74.0 | 6.32 | 171 | 0.00 % | 19.6 % | 17.4 % | 10.0 |
Indoco Remedies Ltd | 2,217 Cr. | 240 | 388/190 | | 118 | 0.63 % | 10.4 % | 8.33 % | 2.00 |
Hikal Ltd | 5,110 Cr. | 415 | 465/267 | 68.6 | 97.6 | 0.29 % | 7.79 % | 5.97 % | 2.00 |
Hester Biosciences Ltd | 1,477 Cr. | 1,733 | 3,379/1,243 | 47.8 | 355 | 0.35 % | 9.32 % | 6.60 % | 10.0 |
Gufic BioSciences Ltd | 3,408 Cr. | 340 | 504/278 | 41.6 | 57.3 | 0.03 % | 17.2 % | 20.0 % | 1.00 |
Granules India Ltd | 11,241 Cr. | 464 | 725/389 | 23.5 | 141 | 0.32 % | 15.4 % | 13.4 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 38,870 Cr. | 1,377 | 1,831/985 | | 299 | 0.18 % | 12.3 % | 50.9 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 48,830 Cr. | 2,878 | 3,088/1,846 | 57.2 | 98.7 | 1.11 % | 51.3 % | 37.3 % | 10.0 |
Gland Pharma Ltd | 23,485 Cr. | 1,426 | 2,221/1,200 | 21.0 | 557 | 1.40 % | 16.7 % | 12.3 % | 1.00 |
FDC Ltd | 6,910 Cr. | 425 | 659/359 | 25.2 | 141 | 1.18 % | 18.4 % | 14.2 % | 1.00 |
ERIS Lifesciences Ltd | 18,819 Cr. | 1,382 | 1,594/816 | 57.1 | 204 | 0.53 % | 11.3 % | 16.3 % | 1.00 |
Dr Reddys Laboratories Ltd | 96,402 Cr. | 1,155 | 1,421/1,020 | 18.0 | 369 | 0.69 % | 26.5 % | 21.4 % | 1.00 |
Dishman Carbogen Amcis Ltd | 3,282 Cr. | 210 | 308/133 | | 366 | 0.00 % | 0.02 % | 2.64 % | 2.00 |
Cipla Ltd | 1,21,127 Cr. | 1,499 | 1,702/1,310 | 24.3 | 351 | 0.87 % | 22.8 % | 16.8 % | 2.00 |
Caplin Point Laboratories Ltd | 14,968 Cr. | 1,971 | 2,641/1,221 | 29.1 | 334 | 0.25 % | 26.5 % | 24.2 % | 2.00 |
Brooks Laboratories Ltd | 428 Cr. | 143 | 203/72.5 | | 22.6 | 0.00 % | 24.7 % | 28.1 % | 10.0 |
Bliss GVS Pharma Ltd | 1,297 Cr. | 123 | 186/92.2 | 15.3 | 95.8 | 0.41 % | 14.4 % | 10.2 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 73.0 Cr. | 45.4 | 92.0/40.4 | 122 | 11.3 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
Biocon Ltd | 39,428 Cr. | 329 | 405/260 | 47.9 | 175 | 0.15 % | 5.96 % | 5.25 % | 5.00 |
Beta Drugs Ltd | 1,839 Cr. | 1,822 | 2,215/1,048 | 44.8 | 179 | 0.00 % | 32.8 % | 26.0 % | 10.0 |
Bal Pharma Ltd | 170 Cr. | 107 | 158/76.3 | 23.5 | 43.2 | 1.12 % | 12.1 % | 11.0 % | 10.0 |
Bafna Pharmaceuticals Ltd | 177 Cr. | 74.9 | 113/67.8 | 37.9 | 35.0 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
Astrazeneca Pharma India Ltd | 21,282 Cr. | 8,511 | 9,168/4,800 | 127 | 272 | 0.28 % | 31.1 % | 22.9 % | 2.00 |
Amrutanjan Health Care Ltd | 1,969 Cr. | 683 | 863/548 | 39.9 | 103 | 0.67 % | 21.3 % | 15.5 % | 1.00 |
Alpa Laboratories Ltd | 234 Cr. | 110 | 145/69.9 | 9.28 | 83.0 | 0.00 % | 13.7 % | 11.2 % | 10.0 |
Alkem Laboratories Ltd | 59,076 Cr. | 4,945 | 6,440/4,407 | 27.3 | 961 | 0.81 % | 19.7 % | 19.6 % | 2.00 |
Alembic Pharmaceuticals Ltd | 16,719 Cr. | 850 | 1,304/725 | 28.2 | 249 | 1.29 % | 13.1 % | 13.3 % | 2.00 |
Albert David Ltd | 483 Cr. | 846 | 1,754/763 | 11.9 | 724 | 1.36 % | 27.8 % | 21.7 % | 10.0 |
Ajanta Pharma Ltd | 32,965 Cr. | 2,638 | 3,486/2,022 | 36.7 | 294 | 1.37 % | 31.6 % | 23.2 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,246 Cr. | 290 | 571/258 | 22.8 | 120 | 1.76 % | 15.2 % | 11.2 % | 2.00 |
Aarti Drugs Limited | 3,288 Cr. | 358 | 635/312 | 24.9 | 126 | 0.28 % | 13.7 % | 12.4 % | 10.0 |
Industry Average | 17,536.69 Cr | 1,109.12 | | 43.04 | 182.59 | 0.35% | 16.00% | 16.30% | 6.24 |